Blincyto (Blinatumomab)
Complete patient guide for uses, dosage, side effects, and safety information
Quick Facts
What Is Blincyto Used For?
Blincyto is a medication that helps treat acute lymphoblastic leukaemia (ALL) by enabling the immune system to target and destroy abnormal white blood cells.
Primary Uses
Blincyto is primarily used to treat acute lymphoblastic leukaemia (ALL), a type of blood cancer characterized by uncontrolled growth of a specific type of white blood cell.
How It Works
Blincyto works by activating the immune system to attack and eliminate cancerous white blood cells.
Good to know: Blincyto is not addictive.
Continue Reading
Sign in to access the complete medication guide including dosage, side effects, warnings, and more.
How to Take Blincyto
Blincyto is administered as an infusion by a healthcare provider. It is important to follow their instructions carefully.
Dosage Instructions
The dosage of Blincyto is determined based on your weight, height, and medical condition. It is given as a continuous infusion into a vein, usually requiring a hospital stay for monitoring.
What If You Miss a Dose?
Since Blincyto is administered by a healthcare professional, missed doses are managed by rescheduling your infusion.
Important: Never attempt to adjust the infusion settings yourself.
Side Effects
Like all medications, this medicine can cause side effects. Most are mild and temporary, but some require medical attention.
Common Side Effects
These side effects occur relatively frequently and usually don’t require emergency care:
- headache
- tingling or numbness
- rash
- cough
- cold-like symptoms
- shortness of breath
- pale skin
- easy bruising or bleeding
- trouble sleeping
- back or bone pain
- pain in hands or feet
- swollen joints
- nosebleeds
- nausea
- diarrhea
- vomiting
- flushing
- dizziness
- tremor
- tiredness
- weight gain
Seek immediate medical attention if you experience:
- fever (38°C or above)
- signs of infection
- infusion-related reactions
- allergic reactions
- neurological problems
- inflammatory conditions
- metabolic disorders
- pancreas inflammation
- decreased white blood cells
Important Warnings
It is crucial to be aware of potential risks and contraindications before starting Blincyto.
Who Should Not Take Blincyto
Do not use Blincyto if you have a known allergy to blinatumomab or any of its ingredients.
Medical Conditions to Discuss
Discuss any history of neurological problems, active infections, or previous infusion reactions with your doctor.
Pregnancy and Breastfeeding
The effects of Blincyto during pregnancy are not well understood. Use effective contraception during treatment and for 48 hours after the last dose. Do not breastfeed during treatment and for at least 48 hours after.
Elderly Patients With Dementia: Elderly patients, particularly those with dementia, may have a higher risk of seizures during treatment.
Drug Interactions
Some medications may interfere with how Blincyto works.
Alcohol & Driving
Avoid alcohol and be cautious when driving or operating machinery while receiving Blincyto.
Alcohol
There are no specific warnings regarding alcohol consumption, but it is advisable to avoid it.
Driving and Operating Machinery
Do not drive or operate heavy machinery as Blincyto may cause dizziness, confusion, or seizures.
Storage
Store Blincyto in a refrigerator at 2°C to 8°C until it is ready for infusion.
Overdose Information
Overdose is unlikely as Blincyto is administered under medical supervision. If you suspect an overdose or experience severe side effects, seek immediate medical attention.
Frequently Asked Questions
The time it takes for Blincyto to work can vary based on individual response to treatment.
Blincyto is given as an infusion and does not have specific food interactions.
No, Blincyto is not considered addictive.
Consult your doctor before stopping Blincyto, as treatment plans are tailored to individual needs.
It is advisable to avoid alcohol while receiving Blincyto.
Weight gain is listed as a common side effect of Blincyto.
Elderly patients, especially those with dementia, may have a higher risk of seizures during treatment.
Since Blincyto is administered by a healthcare professional, missed doses will be managed by rescheduling your infusion.
Important Disclaimer
This information is intended for general educational purposes only and should not be considered medical advice. Always consult your healthcare provider or pharmacist before starting, stopping, or changing any medication.
If you think you may have a medical emergency, call your doctor or emergency services immediately.